skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Liver Cancer remover assunto: Medical Prognosis remover Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Vilgrain, Valérie ; Pereira, Helena ; Guiu, Boris ; Pageaux, Georges-Philippe ; Sibert, Annie ; Bouattour, Mohamed ; Allaham, Wassim ; Laurent, Valérie ; Mathias, Elodie ; Tasu, Jean-Pierre ; Gerolami, René ; Mundler, Olivier ; Seitz, Jean-Francois ; Couturier, Olivier ; Brenot-Rossi, Isabelle ; Sarran, Anthony ; Costentin, Charlotte ; Itti, Emmanuel ; Luciani, Alain ; Adam, René ; Samuel, Didier ; Ronot, Maxime ; Dinut, Aurelia ; Castera, Laurent ; Chatellier, Gilles ; Assenat, Eric ; Delhom - Christol, Elisabeth ; Ilonca, Alina D ; Lonjon, Julie ; Pageaux, Georges-Philippe ; Allaham, Wassim ; Bouattour, Mohamed ; Castera, Laurent ; Dieudonné, Arnaud ; Lebtahi, Rachida ; Ronot, Maxime ; Sibert, Annie ; Vilgrain, Valérie ; Barraud, Hélène ; Bazin, Christophe ; Bronowicki, Jean-Pierre ; Perdrisot, Rémy ; Silvain, Christine ; Tasu, Jean-Pierre ; Borentain, Patrick ; Gerolami, René ; Mundler, Olivier ; Seitz, Jean-Francois ; Vidal, Vincent ; Aubé, Christophe ; Couturier, Olivier ; Oberti, Frédéric ; Vervueren, Laurent ; Brenot-Rossi, Isabelle ; Raoul, Jean-Luc ; Sarran, Anthony ; Chalaye, Julia ; Kobeiter, Hicham ; Luciani, Alain ; Adam, René ; Samuel, Didier ; Frampas, Eric ; Cassinotto, Christophe ; Guyot, Martine ; Bachellier, Philippe ; Detour, Julien ; Duclos, Bernard ; Greget, Michel ; Habersetzer, Francois ; Rode, Agnès ; Morvan, Julie ; Baudin, Guillaume ; Chevallier, Patrick ; Mahamat, Abakar ; Piche, Thierry ; Razzouk, Micheline ; Hillon, Patrick ; Loffroy, Romaric ; Vincent, Julie ; Barabino, Gabriele ; Bouarioua, Nadia ; Cuilleron, Muriel ; Ecochard, Marie ; Prevot-Bitot, Nathalie ; Leroy, Vincent ; Bourcier, Valérie ; Ganne-Carrie, Nathalie ; Seror, Olivier ; Pelage, Jean-Pierre ; Dumortier, Jérôme ; Giammarile, Francesco ; Valette, Pierre-Jean ; Ghazzar, Nadia ; Pellerin, Olivier ; Taieb, Julien ; Weinmann, Pierre ; Heurgue-Berlot, Alexandra ; Marcus, Claude ; Sommacale, Daniele ; Maitre, Sophie

The lancet oncology, 2017-12, Vol.18 (12), p.1624-1636 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Zhu, Andrew X ; Kang, Yoon-Koo ; Yen, Chia-Jui ; Finn, Richard S ; Galle, Peter R ; Llovet, Josep M ; Assenat, Eric ; Brandi, Giovanni ; Pracht, Marc ; Lim, Ho Yeong ; Rau, Kun-Ming ; Motomura, Kenta ; Ohno, Izumi ; Merle, Philippe ; Daniele, Bruno ; Shin, Dong Bok ; Gerken, Guido ; Borg, Christophe ; Hiriart, Jean-Baptiste ; Okusaka, Takuji ; Morimoto, Manabu ; Hsu, Yanzhi ; Abada, Paolo B ; Kudo, Masatoshi

The lancet oncology, 2019-02, Vol.20 (2), p.282-296 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
Material Type:
Artigo 		Adicionar ao Meu Espaço

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Chen, Yunhao ; Peng, Chuanhui ; Chen, Junru ; Chen, Diyu ; Yang, Beng ; He, Bin ; Hu, Wendi ; Zhang, Yanpeng ; Liu, Hua ; Dai, Longfei ; Xie, Haiyang ; Zhou, Lin ; Wu, Jian ; Zheng, Shusen

Molecular cancer, 2019-08, Vol.18 (1), p.127-127, Article 127 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

Jiang, Ying ; Sun, Aihua ; Zhao, Yang ; Ying, Wantao ; Sun, Huichuan ; Yang, Xinrong ; Xing, Baocai ; Sun, Wei ; Ren, Liangliang ; Hu, Bo ; Li, Chaoying ; Zhang, Li ; Qin, Guangrong ; Zhang, Menghuan ; Chen, Ning ; Zhang, Manli ; Huang, Yin ; Zhou, Jinan ; Zhao, Yan ; Liu, Mingwei ; Zhu, Xiaodong ; Qiu, Yang ; Sun, Yanjun ; Huang, Cheng ; Yan, Meng ; Wang, Mingchao ; Liu, Wei ; Tian, Fang ; Xu, Huali ; Zhou, Jian ; Wu, Zhenyu ; Shi, Tieliu ; Zhu, Weimin ; Qin, Jun ; Xie, Lu ; Fan, Jia ; Qian, Xiaohong ; He, Fuchu

Nature (London), 2019-03, Vol.567 (7747), p.257-261 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

Bruix, Jordi ; Cheng, Ann-Lii ; Meinhardt, Gerold ; Nakajima, Keiko ; De Sanctis, Yoriko ; Llovet, Josep

Journal of hepatology, 2017-11, Vol.67 (5), p.999-1008 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
6
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma

Fan, Qing-Min ; Jing, Ying-Ying ; Yu, Guo-Feng ; Kou, Xing-Rui ; Ye, Fei ; Gao, Lu ; Li, Rong ; Zhao, Qiu-Dong ; Yang, Yang ; Lu, Zheng-Hua ; Wei, Li-Xin

Cancer letters, 2014-10, Vol.352 (2), p.160-168 [Periódico revisado por pares]

Ireland: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
7
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

Rimassa, Lorenza ; Assenat, Eric ; Peck-Radosavljevic, Markus ; Pracht, Marc ; Zagonel, Vittorina ; Mathurin, Philippe ; Rota Caremoli, Elena ; Porta, Camillo ; Daniele, Bruno ; Bolondi, Luigi ; Mazzaferro, Vincenzo ; Harris, William ; Damjanov, Nevena ; Pastorelli, Davide ; Reig, María ; Knox, Jennifer ; Negri, Francesca ; Trojan, Jörg ; López López, Carlos ; Personeni, Nicola ; Decaens, Thomas ; Dupuy, Marie ; Sieghart, Wolfgang ; Abbadessa, Giovanni ; Schwartz, Brian ; Lamar, Maria ; Goldberg, Terri ; Shuster, Dale ; Santoro, Armando ; Bruix, Jordi

The lancet oncology, 2018-05, Vol.19 (5), p.682-693 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma

Yang, Beng ; Feng, Xiaode ; Liu, Hua ; Tong, Rongliang ; Wu, Jingbang ; Li, Changbiao ; Yu, Hanxi ; Chen, Yunhao ; Cheng, Qiyang ; Chen, Junru ; Cai, Xianlei ; Wu, Wenxuan ; Lu, Yuejie ; Hu, Jiating ; Liang, Kejiong ; Lv, Zhen ; Wu, Jian ; Zheng, Shusen

Oncogene, 2020-10, Vol.39 (42), p.6529-6543 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Material Type:
Artigo 		Adicionar ao Meu Espaço

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Reig, Maria ; Forner, Alejandro ; Rimola, Jordi ; Ferrer-Fàbrega, Joana ; Burrel, Marta ; Garcia-Criado, Ángeles ; Kelley, Robin K. ; Galle, Peter R. ; Mazzaferro, Vincenzo ; Salem, Riad ; Sangro, Bruno ; Singal, Amit G. ; Vogel, Arndt ; Fuster, Josep ; Ayuso, Carmen ; Bruix, Jordi

Journal of hepatology, 2022-03, Vol.76 (3), p.681-693 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
10
LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR‐128/CD151 pathway in hepatocellular carcinoma
LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR‐128/CD151 pathway in hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR‐128/CD151 pathway in hepatocellular carcinoma

Zhang, Peng‐Fei ; Wang, Fei ; Wu, Jing ; Wu, Yin ; Huang, Wei ; Liu, Dong ; Huang, Xiao‐Yong ; Zhang, Xue‐Mei ; Ke, Ai‐Wu

Journal of cellular physiology, 2019-03, Vol.234 (3), p.2788-2794 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Recursos Online (2.204)
  2. Revistas revisadas por pares (2.127)

Data de Publicação 

De até
Refinar
  1. Antes de2001  (8)
  2. 2001Até2006  (43)
  3. 2007Até2012  (169)
  4. 2013Até2019  (1.390)
  5. Após 2019  (605)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.